| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytokinetics, Incorporated (CYTK) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. CYTK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 400.3K | $31.99M | - | |
| VP | 141.5K | $11.31M | - | |
| Other | 87.3K | $6.98M | - | |
| VP | 73.6K | $5.88M | -15,000 | |
| CFO | 70.1K | $5.60M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2023 | Malik Fady Ibraham55 | EVP Research &Development | Sell | 4,000 | $34.21 | $136,840.00 | -2.3% | -1.8% | +99.2% | |
| Mar 28, 2023 | Blum Robert I51 | President &CEO | Sale+OE | 12,500 | $35.05 | $438,125.00 | -2.8% | -5.8% | +104.1% | |
| Mar 15, 2023 | Blum Robert I51 | President &CEO | Sale+OE | 12,500 | $37.26 | $465,750.00 | -2.8% | -2.5% | +71.0% | |
| Mar 9, 2023 | Malik Fady Ibraham55 | EVP Research &Development | Sell | 4,000 | $39.10 | $156,400.00 | -2.3% | +5.1% | +78.4% | |
| Mar 6, 2023 | Blum Robert I51 | President &CEO | Sale+OE | 12,500 | $39.94 | $499,250.00 | -3.3% | -2.9% | +69.8% | |
| Feb 21, 2023 | Wong Robert46 | VP, Chief Accounting Officer | Sell | 2,234 | $45.21 | $100,999.14 | -8.3% | -3.1% | +82.0% | |
| Feb 9, 2023 | Malik Fady Ibraham55 | EVP Research &Development | Sell | 4,000 | $43.73 | $174,920.00 | -2.6% | -11.4% | +73.7% | |
| Feb 9, 2023 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 7,000 | $43.74 | $306,180.00 | -4.3% | -11.4% | +73.7% | |
| Feb 6, 2023 | Wierenga Wendall59 | Director | Sale+OE | 7,000 | $45.00 | $315,000.00 | -35.8% | -14.3% | +78.8% | |
| Feb 3, 2023 | Jaw Ching47 | SVP Finance &CFO | Sale+OE | 15,000 | $45.00 | $675,000.00 | -18.3% | -12.7% | +81.9% |